Clinical Evaluation of NOV UV Shield (Sunscreen Product) on Its Safety and Utility.
|
Accession number;00A0533985
|
| Title;Clinical Evaluation of NOV UV Shield (Sunscreen Product) on Its Safety and Utility. |
| Author;
FUNASAKA YOKO
(Kobe Univ., Sch. of Med.)
ICHIHASHI MASAMITSU
(Kobe Univ., Sch. of Med.)
NISHIGORI CHIKAKO
(Kyoto Univ., Grad. Sch.)
MIYACHI YOSHIKI
(Kyoto Univ., Grad. Sch.)
UETSU NAOKO
(Kansai Med. Univ.)
HORIO TAKASHI
(Kansai Med. Univ.)
|
Journal Title;Skin Research
|
Journal Code:Z0014B
|
ISSN:0018-1390
|
|
VOL.42;NO.1;PAGE.101-111(2000)
|
| Figure&Table&Reference;FIG.11, REF.13 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;NOV UV SHIELD (a new sunscreen product, SPF35 PA ++) was applied to total 51 cases with photosensitive diseases and dermatologic diseases in 3 university hospitals in Japan during Apr. -Sep., 1999. This sunscreen product has protective function of SPF35, PA ++ by super-fine titanium dioxide as ultraviolet reflactant without using ultraviolet absorbers, and also contains hyaluronic acid and squalane for moisturizing effect, and d-.ALPHA.-tocopherol for the inhibition of free radical formation. Ultraviolet-exposed skin area was observed after 4 weeks application of this product with informed consents. Its safety rate in total 51 cases was 90.2%, utility rate in 45 cases of photosensitive diseases was 88.9%, and side-effect among 51 cases was 3.9%. The extent of complaints was slight, and they disappeared absolutely after the application was stopped. These results indicate that NOV UV SHIELD is a highly safe and efficient sunscreen recommended for photosensitive diseases to protect their skin from ultraviolet irradiation. (author abst.) |
|
|
|
Related Articles;
|
|
